Peptide buying advice on TikTok: what the science actually says

What did @daviddemesquita actually say?

The creator pushed back hard on a commenter claiming follistatin is "the best peptide for building muscle tissue." His core argument: follistatin works in rats, has zero human research supporting it, and even mega-dosing protocols in genetically gifted athletes have produced no visible results. He called it "one of the most expensive peptides ever made" and told viewers spending money on it is a waste.

He was responding to someone promoting follistatin as a superior muscle-building compound, which is a claim that circulates regularly in peptide communities on TikTok and bodybuilding forums. His frustration with the platform as a source of health information was clear throughout, and honestly, it's hard to argue with that frustration.

Does the science back this up?

Largely, yes. The human evidence for injectable follistatin as a bodybuilding compound is essentially nonexistent, and the animal data does not translate cleanly to humans. That said, the biology is genuinely interesting, which is probably why the hype exists in the first place.

Follistatin is an endogenous glycoprotein that binds and neutralizes myostatin, a protein that suppresses muscle growth. In mice with follistatin overexpression or myostatin knockouts, muscle mass increases dramatically (Lee, 2004, PNAS). This is real biology. The problem is that injecting exogenous follistatin peptide fragments does not replicate gene-level overexpression. A 2015 study by Mendias et al. in the Journal of Applied Physiology found that systemic myostatin inhibition in adult mice produced modest hypertrophy but significant tendon weakness, raising safety questions even in animals. Human gene therapy trials using follistatin constructs for Becker muscular dystrophy (Mendell et al., 2015, Molecular Therapy) showed limited functional improvement in a disease context, not a performance context. There are no randomized controlled trials in healthy adults using injected follistatin for muscle gain.

What did they get wrong (or right)?

The creator got the main point right. There is no human clinical trial data supporting follistatin injections for muscle building, and the anecdotal reports from athletes are unconvincing. He deserves credit for pushing back on this directly rather than hedging.

However, saying there is "zero, zero human research" is slightly imprecise. There is human research on follistatin, just not in a bodybuilding or performance context. The Mendell et al. gene therapy trials are human studies. What does not exist is human evidence for the injectable peptide form used in the bodybuilding space. That distinction matters, because the mechanism is real even if the delivery method used by athletes is not validated.

His claim about "mega dosing protocols" not working is anecdotal, but it aligns with the pharmacological logic. Injected follistatin has poor bioavailability, uncertain receptor targeting, and a half-life that makes systemic muscle signaling effects implausible at doses athletes can realistically use. The biology does not cooperate with the dosing strategy.

What should you actually know?

If you are considering follistatin because you read about myostatin inhibition and it sounds logical, the logic is real but the product being sold to you is not delivering on that mechanism. The peptide fragments sold in the research chemical market are not the same as endogenous follistatin protein or the gene therapy constructs used in clinical settings.

Myostatin inhibition as a concept is an active area of legitimate pharmaceutical research. Companies like Scholar Rock have investigated systemic myostatin inhibitors (apitegromab) in clinical trials for muscle-wasting diseases. None of this research involves injectable follistatin peptides purchased online. The compounds being marketed to bodybuilders under the follistatin label have not cleared basic pharmacokinetic validation in humans, let alone efficacy trials.

The price point the creator mentioned is also worth flagging. Expensive does not mean effective in the peptide market. It often means the synthesis is complex and the demand is driven by hype rather than evidence. Spending significant money on a compound with no human performance data, uncertain purity from unregulated sources, and plausible safety concerns from animal studies is a poor tradeoff.

Bottom line on this video

The creator's skepticism is well-placed and his conclusion is correct. Follistatin injections for muscle building are not supported by human evidence, and the mechanism that makes it theoretically interesting does not translate into a functional product through the delivery methods bodybuilders are actually using. The commenter he was responding to was wrong. The one thing worth adding is that "no human research" should be clarified to mean no human performance research for the injected peptide form. The distinction matters for scientific accuracy, even if the practical conclusion is the same.